Literature DB >> 11260505

Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.

M V Corrias1, M Occhino, M Croce, A De Ambrosis, M P Pistillo, P Bocca, V Pistoia, S Ferrini.   

Abstract

We studied the constitutive and the interferon (IFN)-gamma-induced expression of HLA class I antigen heavy chain, beta2-microglobulin (beta2m), TAP-1, TAP-2 and tapasin in a panel of eleven neuroblastoma cell lines. Surface expression of HLA class I antigens was low in eight out of eight neuroblastoma cell lines bearing MYC-N amplification and/or 1p deletion, while two out of three neuroblastoma cell lines lacking these genetic alterations showed normal expression. IFN-gamma treatment restored HLA class I antigen surface expression in all neuroblastoma cell lines. Eight out of 11 neuroblastoma cell lines did not express TAP-1 mRNA and three of them also lacked TAP-2 mRNA. beta2 m mRNA was barely detectable or absent in five neuroblastoma cell lines, while tapasin mRNA was always expressed. IFN-gamma upregulated the expression of HLA class I heavy chain, beta2 m, TAP-1, TAP-2 and tapasin, as detected at mRNA or protein level. Post-transcriptional events were involved in altered TAP-1 and beta2 m expression in one peculiar neuroblastoma cell line. These data indicate that multiple mechanisms play a role in the HLA class I antigen-deficient phenotype of human neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260505     DOI: 10.1034/j.1399-0039.2001.057002110.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  17 in total

1.  Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.

Authors:  Lizzia Raffaghello; Ignazia Prigione; Irma Airoldi; Marta Camoriano; Isabella Levreri; Claudio Gambini; Daniela Pende; Alexander Steinle; Soldano Ferrone; Vito Pistoia
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

Review 2.  Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy.

Authors:  Raffaella Meazza; Bruno Azzarone; Anna Maria Orengo; Silvano Ferrini
Journal:  J Biomed Biotechnol       Date:  2011-06-13

3.  IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.

Authors:  Fabio Morandi; Michela Croce; Giuliana Cangemi; Sebastiano Barco; Valentina Rigo; Barbara Carlini; Loredana Amoroso; Vito Pistoia; Silvano Ferrini; Maria Valeria Corrias
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

4.  Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.

Authors:  Sara Stigliani; Michela Croce; Fabio Morandi; Paola Scaruffi; Valentina Rigo; Barbara Carlini; Carla Manzitti; Anna Rita Gigliotti; Gian Paolo Tonini; Vito Pistoia; Silvano Ferrini; Maria Valeria Corrias
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

Review 5.  The new deal: a potential role for secreted vesicles in innate immunity and tumor progression.

Authors:  Alberto Benito-Martin; Angela Di Giannatale; Sophia Ceder; Héctor Peinado
Journal:  Front Immunol       Date:  2015-02-24       Impact factor: 7.561

Review 6.  Dual Roles of IL-27 in Cancer Biology and Immunotherapy.

Authors:  Marina Fabbi; Grazia Carbotti; Silvano Ferrini
Journal:  Mediators Inflamm       Date:  2017-02-01       Impact factor: 4.711

Review 7.  Bone Marrow Environment in Metastatic Neuroblastoma.

Authors:  Chiara Brignole; Fabio Pastorino; Patrizia Perri; Loredana Amoroso; Veronica Bensa; Enzo Calarco; Mirco Ponzoni; Maria Valeria Corrias
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

8.  IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.

Authors:  Silvia Lorenzi; Matteo Forloni; Loredana Cifaldi; Chiara Antonucci; Arianna Citti; Renata Boldrini; Marco Pezzullo; Aurora Castellano; Vincenzo Russo; Pierre van der Bruggen; Patrizio Giacomini; Franco Locatelli; Doriana Fruci
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

9.  Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.

Authors:  I Airoldi; R Meazza; M Croce; E Di Carlo; T Piazza; C Cocco; T D'Antuono; V Pistoia; S Ferrini; M V Corrias
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

10.  Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L.

Authors:  I Airoldi; S Lualdi; S Bruno; L Raffaghello; M Occhino; C Gambini; V Pistoia; M V Corrias
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.